Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Loading
Home›
Research›
People›
James Rothman
AddedFeb 13, 2024
UpdatedMay 31, 2026
James Rothman

James Rothman

Board Member, Prellis Biologics

CrunchbaseThe Org

James Rothman's Career

Prellis Biologics
Prellis Biologics

San Francisco, CA, US

Board Member· Board
Epic Sciences
Epic Sciences

San Diego, CA, US

Board Member· Board

Create your profile now and gain access to exclusive deals and high-potential startups.

aVenture product preview
aVenture product preview
aVenture product preview

James Rothman's Career

Prellis Biologics
Prellis Biologics
Series C$79.4M462016San Francisco, CA, US
Board Member· Board

Leadership at Prellis Biologics

Michael MarksMichael MarksBoard Member
Mike NohaileMike NohaileCEO
Melanie MatheuMelanie MatheuCo-Founder
Noelle Huskey MullinNoelle Huskey MullinCo-Founder
Lei MengLei MengBoard Member

Similar to Prellis Biologics

Parallel BioParallel BioCambridge, MA, USDrug Discoveryest. 2021Parallel BioCambridge, MA, US · est. 2021

Parallel Bio: Human immune system platform for drug and vaccine testing.

Seed · $4.6M9
HI-BioHI-BioSan Francisco, CA, USBiotechest. 2021HI-BioSan Francisco, CA, US · est. 2021

HI-Bio pioneers precision medicine, targeting cellular drivers to treat immune-mediated diseases.

Series B · $215M48
Exotech BioExotech BioSan Francisco, CA, USBiotechest. 2016Exotech BioSan Francisco, CA, US · est. 2016

Exotech Bio: Innovating biotech since 2016.

Series A · $5M7
TRex BioTRex BioSouth San Francisco, CA, USTherapeuticsest. 2018TRex BioSouth San Francisco, CA, US · est. 2018

TRexBio: A biotech firm innovating cancer and inflammatory disease therapeutics using advanced computational biology.

Series A · $85M69
Epic Sciences
Epic Sciences
Series G$219.5M1142008San Diego, CA, US
Board Member· Board

Leadership at Epic Sciences

Evgeny ZaytsevEvgeny ZaytsevBoard Member
Greg LucierGreg LucierBoard Member
Kim KamdarKim KamdarBoard Member
Richard EglenRichard EglenBoard Member
Murali PrahaladMurali PrahaladBoard Member
Peter KuhnPeter KuhnFounder

Similar to Epic Sciences

Epi OneEpi OneNew York City, NY, USCancer Diagnosticsest. 2016Epi OneNew York City, NY, US · est. 2016

Revolutionary cancer diagnosis platform for early prognosis, detection, and drug response.

Series B · $22.9M36
EpinomaEpinomaSan Francisco, CA, USCancer Diagnosticsest. 2020EpinomaSan Francisco, CA, US · est. 2020

Innovative diagnostics company using multi-omics for cancer monitoring. Founded in 2020, based in San Francisco.

Pre-Seed · $125k6
OnCirc DiagnosticsOnCirc DiagnosticsBeverly Hills, CA, USCancer Diagnosticsest. 2009OnCirc DiagnosticsBeverly Hills, CA, US · est. 2009

Innovative cancer diagnostics biotech in Beverly Hills.

Pre-Seed · $500k30
Exact SciencesExact SciencesMadison, WI, USCancer Diagnosticsest. 1995Exact SciencesMadison, WI, US · est. 1995

Exact Sciences Corp., a US-based firm, develops non-invasive tests for early colorectal cancer detection.

Public · $2.1B6.4k

James Rothman's Similar Executives & Operators

Lau Eng BoonLau Eng BoonBoard Member · BukalapakJay Geoffrey WacherJay Geoffrey WacherBoard Member · BukalapakSoemantri BrodjonegoroSoemantri BrodjonegoroBoard Member · BukalapakWILL WEI CHENGWILL WEI CHENGBoard Member · DiDiDhirubhai H. AmbaniDhirubhai H. AmbaniBoard Member · Reliance RetailMason YeoMason YeoBoard Member · KakaoJaeHong ChoiJaeHong ChoiBoard Member · KakaoSean JohSean JohBoard Member · Kakao

People Similar to James Rothman

Irwin JacobsIrwin JacobsCo-Founder · QualcommKingsley LeungKingsley LeungBoard Member · Great Bay BioBill HeidenBill HeidenBoard Member · Atara BiotherapeuticsBob RosenthalBob RosenthalBoard Member · Bruker BioSpinGlenn MattesGlenn MattesBoard Member · Viking ScientificDan PetersonDan PetersonBoard Member · BioCrossroads